Corbevax

The recently approved heterologous Covid-19 vaccine, Biological E Limited (BE) Corbevax is expected to be available as a booster dose on the COWIN App in both public and private vaccination centres from today - August 12, 2022. Corbevax…
Read More...

Biological E Limited’s Corbevax has become the first Covid-19 vaccine in India to be approved by the Drug Controller General of India (DCGI) as a heterologous Covid-19 booster dose. This means that adults fully vaccinated with Covishield…
Read More...

With parts of India facing yet another surge in Covid cases, though so far subdued compared to earlier waves, the Subject Expert Committee of the Drugs Controller General of India has proposed emergency use of Corbevax vaccine for children…
Read More...

The Drugs Controller General of India has granted restricted emergency use authorisation (EUA) to Biological E's COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions, official sources said on Monday.…
Read More...

Amid the sudden surge in COVID-19 cases due to Omicron and the need for booster doses for better protection, Biological E has been given the nod by the Drug Controller General of India (DCGI) to conduct phase 3 trials of its vaccine…
Read More...

Drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved vaccines Corbevax, Covovax, anti-viral drug Molnupiravir for restricted emergency use against COVID-19. Union Health Minister Mansukh Mandaviya on…
Read More...